These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 6314060

  • 1. Prognostic significance of N1 disease in carcinoma of the lung.
    Martini N, Flehinger BJ, Nagasaki F, Hart B.
    J Thorac Cardiovasc Surg; 1983 Nov; 86(5):646-53. PubMed ID: 6314060
    [Abstract] [Full Text] [Related]

  • 2. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
    Ferguson MK, Little AG, Golomb HM, Hoffman PC, DeMeester TR, Beveridge R, Skinner DB.
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
    [Abstract] [Full Text] [Related]

  • 3. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
    McCaughan BC, Martini N, Bains MS, McCormack PM.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
    [Abstract] [Full Text] [Related]

  • 4. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB, DeMeester TR, Golomb HM, Hoffman PC, Little AG, Raghavan V.
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 6. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
    Mitchell JD, Mathisen DJ, Wright CD, Wain JC, Donahue DM, Allan JS, Moncure AC, Grillo HC.
    J Thorac Cardiovasc Surg; 2001 Mar; 121(3):465-71. PubMed ID: 11241081
    [Abstract] [Full Text] [Related]

  • 7. Sleeve lobectomy for carcinoma of the lung.
    Weisel RD, Cooper JD, Delarue NC, Theman TE, Todd TR, Pearson FG.
    J Thorac Cardiovasc Surg; 1979 Dec; 78(6):839-49. PubMed ID: 228125
    [Abstract] [Full Text] [Related]

  • 8. A contribution on the prognostic significance of the tumor formula (pTNM) in squamous cell carcinoma of the bronchus.
    Huwer H, Volkmer I, Hülsewede R, Hausinger F.
    Thorac Cardiovasc Surg; 1989 Oct; 37(5):281-4. PubMed ID: 2588245
    [Abstract] [Full Text] [Related]

  • 9. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A.
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, Bedirhan MA, Gurses A, Dincer SI.
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [Abstract] [Full Text] [Related]

  • 11. Prognostic evaluation of tracheobronchial reconstruction for bronchogenic carcinoma.
    Fujimura S, Kondo T, Imai T, Yamauchi A, Handa M, Okabe T, Nakada T.
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):161-6. PubMed ID: 2991667
    [Abstract] [Full Text] [Related]

  • 12. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [Abstract] [Full Text] [Related]

  • 13. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB.
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [Abstract] [Full Text] [Related]

  • 14. The present status of surgery for lung cancer.
    Lacquet LK.
    Acta Chir Belg; 1996 Jul; 96(6):245-51. PubMed ID: 9008764
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A.
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [Abstract] [Full Text] [Related]

  • 16. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [Abstract] [Full Text] [Related]

  • 17. Prognosis for resected lung cancer patients with tumors greater than ten centimeters in diameter.
    Sano T, Naruke T, Kondo H, Goya T, Tsuchiya R, Suemasu K.
    Jpn J Clin Oncol; 1990 Dec; 20(4):369-73. PubMed ID: 2283720
    [Abstract] [Full Text] [Related]

  • 18. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C.
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [Abstract] [Full Text] [Related]

  • 19. Bronchoplastic procedures and pulmonary artery reconstruction in the treatment of bronchogenic cancer.
    Belli L, Meroni A, Rondinara G, Beati CA.
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):167-71. PubMed ID: 2991668
    [Abstract] [Full Text] [Related]

  • 20. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, Allen MS, Pairolero PC.
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.